annual ROE:
33.08%-43.47%(-56.79%)Summary
- As of today (August 20, 2025), PTCT annual return on equity is 33.08%, with the most recent change of -43.47% (-56.79%) on December 31, 2024.
- During the last 3 years, PTCT annual ROE has risen by +249.83% (+115.26%).
- PTCT annual ROE is now -79.46% below its all-time high of 161.06%, reached on December 31, 2022.
Performance
PTCT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-98.90%-27.20%(-37.94%)Summary
- As of today (August 20, 2025), PTCT quarterly return on equity is -98.90%, with the most recent change of -27.20% (-37.94%) on June 30, 2025.
- Over the past year, PTCT quarterly ROE has dropped by -155.93% (-273.42%).
- PTCT quarterly ROE is now -123.18% below its all-time high of 426.59%, reached on September 30, 2022.
Performance
PTCT quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
PTCT ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.8% | -273.4% |
| 3 y3 years | +115.3% | +98.9% |
| 5 y5 years | +162.1% | -30.5% |
PTCT ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.5% | +115.3% | -123.2% | +98.9% |
| 5 y | 5-year | -79.5% | +115.3% | -123.2% | +98.9% |
| alltime | all time | -79.5% | +104.7% | -123.2% | +98.9% |
PTCT ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -98.90%(+37.9%) |
| Mar 2025 | - | -71.70%(-298.7%) |
| Dec 2024 | 33.08%(-56.8%) | 36.09%(-25.4%) |
| Sep 2024 | - | 48.38%(-15.2%) |
| Jun 2024 | - | 57.03%(-27.1%) |
| Mar 2024 | - | 78.21%(-21.2%) |
| Dec 2023 | 76.55%(-52.5%) | 99.22%(-20.6%) |
| Sep 2023 | - | 124.92%(-18.6%) |
| Jun 2023 | - | 153.47%(-18.5%) |
| Mar 2023 | - | 188.26%(-28.7%) |
| Dec 2022 | 161.06%(-174.3%) | 264.06%(-38.1%) |
| Sep 2022 | - | 426.59%(-104.6%) |
| Jun 2022 | - | -9218.07%(+1683.4%) |
| Mar 2022 | - | -516.88%(+112.6%) |
| Dec 2021 | -216.75%(+166.2%) | -243.11%(+69.6%) |
| Sep 2021 | - | -143.35%(+50.6%) |
| Jun 2021 | - | -95.17%(+0.0%) |
| Mar 2021 | - | -95.13%(+16.7%) |
| Dec 2020 | -81.42%(+52.9%) | -81.49%(+6.0%) |
| Sep 2020 | - | -76.91%(+1.5%) |
| Jun 2020 | - | -75.81%(+44.7%) |
| Mar 2020 | - | -52.39%(+8.7%) |
| Dec 2019 | -53.24%(+5.4%) | -48.19%(+4.2%) |
| Sep 2019 | - | -46.26%(-12.9%) |
| Jun 2019 | - | -53.14%(-2.0%) |
| Mar 2019 | - | -54.25%(+11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | -50.51%(-11.8%) | -48.85%(+37.7%) |
| Sep 2018 | - | -35.48%(+3.1%) |
| Jun 2018 | - | -34.42%(-28.1%) |
| Mar 2018 | - | -47.85%(-16.1%) |
| Dec 2017 | -57.24%(-30.4%) | -57.04%(-28.0%) |
| Sep 2017 | - | -79.17%(+1.6%) |
| Jun 2017 | - | -77.95%(-13.4%) |
| Mar 2017 | - | -89.96%(+7.3%) |
| Dec 2016 | -82.24%(+26.5%) | -83.85%(+0.6%) |
| Sep 2016 | - | -83.39%(+5.8%) |
| Jun 2016 | - | -78.85%(+10.1%) |
| Mar 2016 | - | -71.62%(+10.6%) |
| Dec 2015 | -65.00%(+50.8%) | -64.78%(+13.9%) |
| Sep 2015 | - | -56.85%(+8.2%) |
| Jun 2015 | - | -52.52%(+10.9%) |
| Mar 2015 | - | -47.36%(+11.6%) |
| Dec 2014 | -43.10%(-47.3%) | -42.45%(-3.7%) |
| Sep 2014 | - | -44.08%(+30.2%) |
| Jun 2014 | - | -33.85%(-4.5%) |
| Mar 2014 | - | -35.46%(-12.7%) |
| Dec 2013 | -81.86%(-88.4%) | -40.61%(+24.0%) |
| Sep 2013 | - | -32.74%(-57.3%) |
| Jun 2013 | - | -76.59%(-49.5%) |
| Mar 2013 | - | -151.77%(-541.6%) |
| Dec 2012 | -708.63%(+455.5%) | 34.37% |
| Dec 2011 | -127.57% | - |
FAQ
- What is PTC Therapeutics, Inc. annual return on equity?
- What is the all time high annual ROE for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. annual ROE year-on-year change?
- What is PTC Therapeutics, Inc. quarterly return on equity?
- What is the all time high quarterly ROE for PTC Therapeutics, Inc.?
- What is PTC Therapeutics, Inc. quarterly ROE year-on-year change?
What is PTC Therapeutics, Inc. annual return on equity?
The current annual ROE of PTCT is 33.08%
What is the all time high annual ROE for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high annual return on equity is 161.06%
What is PTC Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, PTCT annual return on equity has changed by -43.47% (-56.79%)
What is PTC Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of PTCT is -98.90%
What is the all time high quarterly ROE for PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. all-time high quarterly return on equity is 426.59%
What is PTC Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, PTCT quarterly return on equity has changed by -155.93% (-273.42%)